US Patent Issued to Rutgers, The State University of New Jersey, EMORY UNIVERSITY on Sept. 15 for "Targeting deltaFosB for treatment of dyskinesia" (American, Japanese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,726, issued on Sept. 15, was assigned to Rutgers, The State University of New Jersey (New Brunswick, N.J.) and EMORY UNIVERSITY (Atlanta).

"Targeting deltaFosB for treatment of dyskinesia" was invented by Mary M. Mouradian (Princeton, N.J.), Stella Papa (Atlanta), Jie Zhang (East Brunswick, N.J.) and Goichi Beck (Osaka, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compositions, non-viral vectors, recombinant viruses, and recombinant viral vectors for inhibiting triangleFosB expression or activity in a cell and for treating dyskinesia in a subject (e.g., a human patient having Parkinson's disease and Levodopa-induced dyskinesia) include a nu...